Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI

Author

Caterina Bernetti

h-index 12 View on Semantic Scholar

We have 4 of 62 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Exploring the role of glymphatic system in Alzheimer's disease with insights from MRI-based studies: a systematic review.

MRI derived biomarkers, particularly DTI-ALPS index and ePVSs analysis, demonstrate high potential as surrogate indicators of glymphatic impairment in AD, warranting harmonization of imaging protocols and longitudinal investigations to establish their translational utility in clinical biomarker frameworks.

Caterina Bernetti, R. Calandrelli, Fabio Pilato et al. · 0 citations
Sep 2026

Estimating anti-amyloid therapy eligibility in Alzheimer's disease: A real-world retrospective study from an Italian memory clinic.

BackgroundAmyloid-targeting therapies (ATTs) such as donanemab may change the management of Alzheimer's disease (AD). However, ATTs require meticulous eligibility assessment to optimize the benefit-to-risk ratio.ObjectiveTo quantify the proportion of patients eligible for donanemab in a real-world Italian memory clinic...

F. Motolese, F. Ursini, D. Norata et al. · 0 citations
Open access Aug 2026

Ultra-high-field MRI reveals a venous-dominant microbleed phenotype in cerebral amyloid angiopathy: a comparative study versus 3 Tesla MRI.

7T MRI robustly improves CMB detection in CAA and provides higher inter-rater reliability for vCMB classification than 3T, but weak cross-scanner correlation and agreement for the vCMB-to-total ratio preclude interchangeability across field strengths.

D. Botta, Caterina Bernetti, Jose Federico Ojeda Esparza et al. · 0 citations
Review Open access Aug 2026

Advanced neuroimaging of vascular cognitive impairment and dementia: biomarkers, guidelines, and clinical impact.

Current limitations of standardisation, reproducibility, and external validation that remain prerequisites before quantitative VCID imaging achieves formal regulatory biomarker qualification are outlined.

Jose Federico Ojeda-Esparza, D. Botta, A. Fitsiori et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.